CASI Pharmaceuticals (CASIF) Other Working Capital Changes (2020 - 2025)

CASI Pharmaceuticals has reported Other Working Capital Changes for 5 years, with the latest figure at $19875.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Working Capital Changes fell 90.51% year-over-year to $19875.0; the trailing twelve-month figure through Dec 2025 stood at $19875.0 (down 90.51% YoY), and the FY2025 full-year result was $19875.0, down 90.51% from the prior year.
• Other Working Capital Changes for Q4 2025 stood at $19875.0, down from $209389.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $209389.0 in Q4 2024, with the low at $19875.0 in Q4 2025.
• Historically, Other Working Capital Changes has averaged $85035.5 across 4 years, with a median of $55439.0 in 2021.
• Annual changes were most pronounced in 2021 — Other Working Capital Changes surged 228.83% — and 2025, when it slumped 90.51%.
• CASI Pharmaceuticals' Other Working Capital Changes stood at $38700.0 in 2021, then soared by 86.51% to $72178.0 in 2023, then surged by 190.1% to $209389.0 in 2024, then tumbled by 90.51% to $19875.0 in 2025.
• The last three Other Working Capital Changes figures came in at $19875.0 (Q4 2025), $209389.0 (Q4 2024), and $72178.0 (Q4 2023), per Business Quant data.